Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Levetiracetam does not improve cerebellar symptoms of multiple sclerosis

Oct. 19, 2010

PEGylated opioid analgesic NKTR-181 demonstrates slowed entry into CNS

Oct. 19, 2010

DCVax-L is well tolerated combined with other anticancer agents in ovarian cancer

Oct. 19, 2010

Phase I trials assess safety, tolerability and pharmacokinetics of ASM-024

Oct. 19, 2010

Preclinical and clinical data presented on antibiotic CB-183315

Oct. 19, 2010

Snapshots: Preclinical and early clinical development of GSK-1322322

Oct. 18, 2010

Scientists explore antibacterial potential of GE-2270 analogues

Oct. 18, 2010

OC-000459 inhibits late-phase airway response after allergen challenge in patients with asthma

Oct. 18, 2010

Tiotropium/olodaterol combination more effective than tiotropium in COPD

Oct. 18, 2010

Trius Therapeutics develops new antimicrobials targeting dihydrofolate reductase

Oct. 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.